Clinical Trial Update: Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids [Phase 2]

View source ↗

Summary

This update notes that a Phase 2 study of Proellex for symptomatic uterine fibroids in pre-menopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 2 | Status: COMPLETED